Herzinsuffizienz bei Typ-2-Diabetes

Gliflozin bessert Prognose bei Typ-2-Diabetes plus akut verschlechterter Herzschwäche

This is a preview of subscription content, access via your institution.

1

Literatur:

  1. 1.

    Cannon CP, Pratley R, Dagogo-Jack S et al. Cardiovascular outcomes with ertuglifozin in type 2 diabetes. N Engl J Med 2020; 383: 1425-35

  2. 2.

    Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empaglifozin in heart failure. N Engl J Med 2020; 383: 1413-24

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Prof. Dr. med. Emanuel Fritschka.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fritschka, E. Gliflozin bessert Prognose bei Typ-2-Diabetes plus akut verschlechterter Herzschwäche . Info Diabetol 15, 29–30 (2021). https://doi.org/10.1007/s15034-020-3642-4

Download citation